Residential radon, <i>EGFR</i> mutations and <i>ALK</i> alterations in never-smoking lung cancer cases

説明

<jats:p>The aim of this study was to assess if residential radon exposure might cause <jats:italic>EGFR</jats:italic> mutations or <jats:italic>ALK</jats:italic> rearrangements in never-smokers.</jats:p><jats:p>We designed a multicentre case–control study in a radon-prone area (Galicia, Spain); only lung cancer cases were included in the study. We obtained residential radon measurements and clinical information for all the participants. We compared the median values of residential radon between patients with <jats:italic>EGFR</jats:italic> mutations or <jats:italic>ALK</jats:italic> rearrangements <jats:italic>versus</jats:italic> those without them.</jats:p><jats:p>323 patients were included. Median age was 70 years and 19.5% were males. 42 and 15% of patients were <jats:italic>EGFR</jats:italic>- and <jats:italic>ALK</jats:italic>-positive, respectively. The most frequent <jats:italic>EGFR</jats:italic> alterations were exon 19 deletions and exon 21 (L858R) single-point substitution mutations. <jats:italic>ALK</jats:italic>-positive patients were 10 years younger than <jats:italic>ALK</jats:italic>-negative patients. Residential radon levels were two-fold higher in patients with exon 19 deletions compared with patients with exon 21 (L858R) single-point substitution mutations (216 <jats:italic>versus</jats:italic> 118 Bq·m<jats:sup>−3</jats:sup>; p=0.057). There were no differences in residential radon levels by <jats:italic>EGFR</jats:italic> mutation status. <jats:italic>ALK</jats:italic>-positive patients (n=12) essentially had two-fold residential radon levels compared with <jats:italic>ALK</jats:italic>-negative patients (290 <jats:italic>versus</jats:italic> 164 Bq·m<jats:sup>−3</jats:sup>, respectively).</jats:p><jats:p>Residential radon may have a role in the molecular signature of lung cancer in never-smokers, although more studies with larger sample sizes are needed to support this hypothesis.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ